C-Reactive Protein Testing Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
Description
Persistence Market Research has recently released a comprehensive report on the worldwide market for C‑Reactive Protein (CRP) testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global C‑Reactive Protein testing market from 2025 to 2032.
Key Insights:
The C‑Reactive Protein testing market encompasses diagnostic tests that measure CRP levels in blood to assess inflammation linked with cardiovascular disease, infections, autoimmune disorders, and post‑surgical conditions. Key test categories include high‑sensitivity CRP (hs‑CRP) for cardiovascular risk assessment, standard CRP, and point‑of‑care (POC) CRP tests. Assay technologies assessed include immunoturbidimetry, enzyme‑linked immunosorbent assay (ELISA), lateral flow immunoassays, and others. CRP tests are used across hospitals, diagnostic laboratories, clinics, and at decentralized testing locations.
Market Growth Drivers:
The global C‑Reactive Protein testing market is driven by the rising prevalence of chronic inflammatory and cardiovascular diseases, increasing incorporation of CRP testing in preventive healthcare and routine health check‑ups, and growing adoption of rapid POC diagnostics that reduce turnaround time. Technological advancements in immunoassay platforms and expanding awareness of hs‑CRP’s role in early detection of cardiovascular risks further support market growth.
Market Restraints:
Despite positive growth prospects, the market faces challenges related to limited specificity of CRP biomarkers in distinguishing between bacterial and viral infections at low/moderate concentrations, variable analytical performance across POC devices, and inconsistencies in CRP reference ranges across different populations. These factors can limit clinician confidence and adoption in certain settings.
Market Opportunities:
Significant opportunities lie in the integration of CRP testing with telehealth services, remote patient‑monitoring models, and at‑home testing kits to support chronic disease management. Expansion of CRP‑procalcitonin (PCT) duplex tests for faster sepsis triage and continued development of microfluidic and smartphone‑enabled quantitative CRP technologies can further accelerate market penetration.
Key Questions Answered in the Report:
Leading players in the C‑Reactive Protein testing market focus on expanding their assay portfolios, investing in rapid and quantitative POC solutions, and forming strategic collaborations to strengthen market positions. Emphasis on integrating testing systems with laboratory information systems and developing high‑sensitivity CRP assays for preventive care applications helps companies differentiate in increasingly competitive environments.
Key Companies Profiled:
By Test Type:
Please Note: It will take 5 business days to complete the report upon order confirmation.
Key Insights:
- C‑Reactive Protein Testing Market Size (2025E): USD 2.85 Billion
- Projected Market Value (2032F): USD 3.98 Billion
- Global Market Growth Rate (CAGR 2025 to 2032): 4.9%
The C‑Reactive Protein testing market encompasses diagnostic tests that measure CRP levels in blood to assess inflammation linked with cardiovascular disease, infections, autoimmune disorders, and post‑surgical conditions. Key test categories include high‑sensitivity CRP (hs‑CRP) for cardiovascular risk assessment, standard CRP, and point‑of‑care (POC) CRP tests. Assay technologies assessed include immunoturbidimetry, enzyme‑linked immunosorbent assay (ELISA), lateral flow immunoassays, and others. CRP tests are used across hospitals, diagnostic laboratories, clinics, and at decentralized testing locations.
Market Growth Drivers:
The global C‑Reactive Protein testing market is driven by the rising prevalence of chronic inflammatory and cardiovascular diseases, increasing incorporation of CRP testing in preventive healthcare and routine health check‑ups, and growing adoption of rapid POC diagnostics that reduce turnaround time. Technological advancements in immunoassay platforms and expanding awareness of hs‑CRP’s role in early detection of cardiovascular risks further support market growth.
Market Restraints:
Despite positive growth prospects, the market faces challenges related to limited specificity of CRP biomarkers in distinguishing between bacterial and viral infections at low/moderate concentrations, variable analytical performance across POC devices, and inconsistencies in CRP reference ranges across different populations. These factors can limit clinician confidence and adoption in certain settings.
Market Opportunities:
Significant opportunities lie in the integration of CRP testing with telehealth services, remote patient‑monitoring models, and at‑home testing kits to support chronic disease management. Expansion of CRP‑procalcitonin (PCT) duplex tests for faster sepsis triage and continued development of microfluidic and smartphone‑enabled quantitative CRP technologies can further accelerate market penetration.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the CRP testing market globally?
- Which test types and assay technologies are gaining prominence?
- How are innovations in point‑of‑care diagnostics reshaping the competitive landscape?
- Who are the leading companies in the C‑Reactive Protein testing market?
- What are the emerging trends and future prospects across major regions?
Leading players in the C‑Reactive Protein testing market focus on expanding their assay portfolios, investing in rapid and quantitative POC solutions, and forming strategic collaborations to strengthen market positions. Emphasis on integrating testing systems with laboratory information systems and developing high‑sensitivity CRP assays for preventive care applications helps companies differentiate in increasingly competitive environments.
Key Companies Profiled:
- Abbott Laboratories
- F. Hoffmann‑La Roche Ltd.
- Siemens Healthineers AG
- Beckman Coulter, Inc. (Danaher Corporation)
- Thermo Fisher Scientific Inc.
- Randox Laboratories Ltd.
- Ortho Clinical Diagnostics
- Quest Diagnostics Incorporated
- Bio‑Rad Laboratories, Inc.
- Horiba, Ltd.
- Sysmex Corporation
- Tosoh Corporation
- DiaSorin S.p.A.
- Merck KGaA
- Becton, Dickinson and Company (BD)
- Abaxis, Inc.
- Biosystems S.A.
- Genrui Biotech Inc.
- Shenzhen Mindray Bio‑Medical Electronics Co., Ltd.
- Helena Laboratories Corporation
By Test Type:
- High‑Sensitivity CRP (hs‑CRP) Test
- Standard CRP Test
- Point‑of‑Care CRP Test
- CRP Velocity/Serial Monitoring
- Immunoturbidimetry
- Enzyme‑Linked Immunosorbent Assay (ELISA)
- Lateral Flow Immunoassay
- Chemiluminescent Immunoassay (CLIA)
- Nephelometry
- Serum
- Plasma
- Whole Blood
- Dried Blood Spot (DBS)
- Cardiovascular Disease Risk Assessment
- Infectious Disease Diagnosis
- Sepsis Detection
- Inflammatory and Autoimmune Disorder Monitoring
- Post‑Surgical Recovery Monitoring
- North America
- Europe
- Asia Pacific
- South Asia & Oceania
- Latin America
- Middle East & Africa
Please Note: It will take 5 business days to complete the report upon order confirmation.
Table of Contents
198 Pages
- 1. Executive Summary
- 1.1. Global C-Reactive Protein Testing Market Snapshot, 2025 and 2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
- 2.3. Macro-economic Factors
- 2.3.1. Global Sectoral Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
- 3. Value Added Insights
- 3.1. Tool Adoption Analysis
- 3.2. Regulatory Landscape
- 3.3. Value Chain Analysis
- 3.4. PESTLE Analysis
- 3.5. Porter’s Five Force Analysis
- 4. Price Analysis, 2024A
- 4.1. Key Highlights
- 4.2. Key Factors Impacting Deployment Costs
- 4.3. Pricing Analysis, By Component Type
- 5. Global C-Reactive Protein Testing Market Outlook
- 5.1. Key Highlights
- 5.1.1. Market Volume (Units) Projections
- 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
- 5.2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 5.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
- 5.3. Global C-Reactive Protein Testing Market Outlook: Test Type
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Test Type, 2019-2024
- 5.3.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
- 5.3.3.1. High-Sensitivity CRP (hs-CRP) Test
- 5.3.3.2. Standard CRP Test
- 5.3.3.3. Point-of-Care CRP Test
- 5.3.3.4. CRP Velocity/Serial Monitoring
- 5.3.4. Market Attractiveness Analysis: Test Type
- 5.4. Global C-Reactive Protein Testing Market Outlook: Assay Technology
- 5.4.1. Introduction / Key Findings
- 5.4.2. Historical Market Size (US$ Bn) Analysis, By Assay Technology, 2019-2024
- 5.4.3. Market Size (US$ Bn) Analysis and Forecast, By Assay Technology, 2025-2032
- 5.4.3.1. Immunoturbidimetry
- 5.4.3.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 5.4.3.3. Lateral Flow Immunoassay
- 5.4.3.4. Chemiluminescent Immunoassay (CLIA)
- 5.4.3.5. Nephelometry
- 5.4.4. Market Attractiveness Analysis: Assay Technology
- 5.5. Global C-Reactive Protein Testing Market Outlook: Sample Type
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Bn) Analysis, By Sample Type, 2019-2024
- 5.5.3. Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025-2032
- 5.5.3.1. Serum
- 5.5.3.2. Plasma
- 5.5.3.3. Whole Blood
- 5.5.3.4. Dried Blood Spot (DBS)
- 5.5.4. Market Attractiveness Analysis: Sample Type
- 5.6. Global C-Reactive Protein Testing Market Outlook: Application
- 5.6.1. Introduction / Key Findings
- 5.6.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
- 5.6.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 5.6.3.1. Cardiovascular Disease Risk Assessment
- 5.6.3.2. Infectious Disease Diagnosis
- 5.6.3.3. Sepsis Detection
- 5.6.3.4. Inflammatory and Autoimmune Disorder Monitoring
- 5.6.3.5. Post-Surgical Recovery Monitoring
- 5.6.4. Market Attractiveness Analysis: Application
- 6. Global C-Reactive Protein Testing Market Outlook: Region
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2024
- 6.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
- 6.4. Market Attractiveness Analysis: Region
- 7. North America C-Reactive Protein Testing Market Outlook
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Test Type
- 7.2.3. By Assay Technology
- 7.2.4. By Sample Type
- 7.2.5. By Application
- 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
- 7.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
- 7.4.1. High-Sensitivity CRP (hs-CRP) Test
- 7.4.2. Standard CRP Test
- 7.4.3. Point-of-Care CRP Test
- 7.4.4. CRP Velocity/Serial Monitoring
- 7.5. Market Size (US$ Bn) Analysis and Forecast, By Assay Technology, 2025-2032
- 7.5.1. Immunoturbidimetry
- 7.5.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 7.5.3. Lateral Flow Immunoassay
- 7.5.4. Chemiluminescent Immunoassay (CLIA)
- 7.5.5. Nephelometry
- 7.6. Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025-2032
- 7.6.1. Serum
- 7.6.2. Plasma
- 7.6.3. Whole Blood
- 7.6.4. Dried Blood Spot (DBS)
- 7.7. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 7.7.1. Cardiovascular Disease Risk Assessment
- 7.7.2. Infectious Disease Diagnosis
- 7.7.3. Sepsis Detection
- 7.7.4. Inflammatory and Autoimmune Disorder Monitoring
- 7.7.5. Post-Surgical Recovery Monitoring
- 7.8. Market Attractiveness Analysis
- 8. Europe C-Reactive Protein Testing Market Outlook
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Test Type
- 8.2.3. By Assay Technology
- 8.2.4. By Sample Type
- 8.2.5. By Application
- 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
- 8.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
- 8.4.1. High-Sensitivity CRP (hs-CRP) Test
- 8.4.2. Standard CRP Test
- 8.4.3. Point-of-Care CRP Test
- 8.4.4. CRP Velocity/Serial Monitoring
- 8.5. Market Size (US$ Bn) Analysis and Forecast, By Assay Technology, 2025-2032
- 8.5.1. Immunoturbidimetry
- 8.5.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 8.5.3. Lateral Flow Immunoassay
- 8.5.4. Chemiluminescent Immunoassay (CLIA)
- 8.5.5. Nephelometry
- 8.6. Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025-2032
- 8.6.1. Serum
- 8.6.2. Plasma
- 8.6.3. Whole Blood
- 8.6.4. Dried Blood Spot (DBS)
- 8.7. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 8.7.1. Cardiovascular Disease Risk Assessment
- 8.7.2. Infectious Disease Diagnosis
- 8.7.3. Sepsis Detection
- 8.7.4. Inflammatory and Autoimmune Disorder Monitoring
- 8.7.5. Post-Surgical Recovery Monitoring
- 8.8. Market Attractiveness Analysis
- 9. East Asia C-Reactive Protein Testing Market Outlook
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Test Type
- 9.2.3. By Assay Technology
- 9.2.4. By Sample Type
- 9.2.5. By Application
- 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
- 9.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
- 9.4.1. High-Sensitivity CRP (hs-CRP) Test
- 9.4.2. Standard CRP Test
- 9.4.3. Point-of-Care CRP Test
- 9.4.4. CRP Velocity/Serial Monitoring
- 9.5. Market Size (US$ Bn) Analysis and Forecast, By Assay Technology, 2025-2032
- 9.5.1. Immunoturbidimetry
- 9.5.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 9.5.3. Lateral Flow Immunoassay
- 9.5.4. Chemiluminescent Immunoassay (CLIA)
- 9.5.5. Nephelometry
- 9.6. Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025-2032
- 9.6.1. Serum
- 9.6.2. Plasma
- 9.6.3. Whole Blood
- 9.6.4. Dried Blood Spot (DBS)
- 9.7. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 9.7.1. Cardiovascular Disease Risk Assessment
- 9.7.2. Infectious Disease Diagnosis
- 9.7.3. Sepsis Detection
- 9.7.4. Inflammatory and Autoimmune Disorder Monitoring
- 9.7.5. Post-Surgical Recovery Monitoring
- 9.8. Market Attractiveness Analysis
- 10. South Asia & Oceania C-Reactive Protein Testing Market Outlook
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Test Type
- 10.2.3. By Assay Technology
- 10.2.4. By Sample Type
- 10.2.5. By Application
- 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
- 10.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
- 10.4.1. High-Sensitivity CRP (hs-CRP) Test
- 10.4.2. Standard CRP Test
- 10.4.3. Point-of-Care CRP Test
- 10.4.4. CRP Velocity/Serial Monitoring
- 10.5. Market Size (US$ Bn) Analysis and Forecast, By Assay Technology, 2025-2032
- 10.5.1. Immunoturbidimetry
- 10.5.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 10.5.3. Lateral Flow Immunoassay
- 10.5.4. Chemiluminescent Immunoassay (CLIA)
- 10.5.5. Nephelometry
- 10.6. Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025-2032
- 10.6.1. Serum
- 10.6.2. Plasma
- 10.6.3. Whole Blood
- 10.6.4. Dried Blood Spot (DBS)
- 10.7. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 10.7.1. Cardiovascular Disease Risk Assessment
- 10.7.2. Infectious Disease Diagnosis
- 10.7.3. Sepsis Detection
- 10.7.4. Inflammatory and Autoimmune Disorder Monitoring
- 10.7.5. Post-Surgical Recovery Monitoring
- 10.8. Market Attractiveness Analysis
- 11. Latin America C-Reactive Protein Testing Market Outlook
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Test Type
- 11.2.3. By Assay Technology
- 11.2.4. By Sample Type
- 11.2.5. By Application
- 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
- 11.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
- 11.4.1. High-Sensitivity CRP (hs-CRP) Test
- 11.4.2. Standard CRP Test
- 11.4.3. Point-of-Care CRP Test
- 11.4.4. CRP Velocity/Serial Monitoring
- 11.5. Market Size (US$ Bn) Analysis and Forecast, By Assay Technology, 2025-2032
- 11.5.1. Immunoturbidimetry
- 11.5.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 11.5.3. Lateral Flow Immunoassay
- 11.5.4. Chemiluminescent Immunoassay (CLIA)
- 11.5.5. Nephelometry
- 11.6. Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025-2032
- 11.6.1. Serum
- 11.6.2. Plasma
- 11.6.3. Whole Blood
- 11.6.4. Dried Blood Spot (DBS)
- 11.7. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 11.7.1. Cardiovascular Disease Risk Assessment
- 11.7.2. Infectious Disease Diagnosis
- 11.7.3. Sepsis Detection
- 11.7.4. Inflammatory and Autoimmune Disorder Monitoring
- 11.7.5. Post-Surgical Recovery Monitoring
- 11.8. Market Attractiveness Analysis
- 12. Middle East & Africa C-Reactive Protein Testing Market Outlook
- 12.1. Key Highlights
- 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 12.2.1. By Country
- 12.2.2. By Test Type
- 12.2.3. By Assay Technology
- 12.2.4. By Sample Type
- 12.2.5. By Application
- 12.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
- 12.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
- 12.4.1. High-Sensitivity CRP (hs-CRP) Test
- 12.4.2. Standard CRP Test
- 12.4.3. Point-of-Care CRP Test
- 12.4.4. CRP Velocity/Serial Monitoring
- 12.5. Market Size (US$ Bn) Analysis and Forecast, By Assay Technology, 2025-2032
- 12.5.1. Immunoturbidimetry
- 12.5.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 12.5.3. Lateral Flow Immunoassay
- 12.5.4. Chemiluminescent Immunoassay (CLIA)
- 12.5.5. Nephelometry
- 12.6. Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025-2032
- 12.6.1. Serum
- 12.6.2. Plasma
- 12.6.3. Whole Blood
- 12.6.4. Dried Blood Spot (DBS)
- 12.7. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 12.7.1. Cardiovascular Disease Risk Assessment
- 12.7.2. Infectious Disease Diagnosis
- 12.7.3. Sepsis Detection
- 12.7.4. Inflammatory and Autoimmune Disorder Monitoring
- 12.7.5. Post-Surgical Recovery Monitoring
- 12.8. Market Attractiveness Analysis
- 13. Competition Landscape
- 13.1. Market Share Analysis, 2024
- 13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
- 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Abbott Laboratories
- 13.3.1.1. Overview
- 13.3.1.2. Segments and Components
- 13.3.1.3. Key Financials
- 13.3.1.4. Market Developments
- 13.3.1.5. Market Strategy
- 13.3.2. F. Hoffmann-La Roche Ltd
- 13.3.3. Siemens Healthineers AG
- 13.3.4. Beckman Coulter, Inc. (Danaher Corporation)
- 13.3.5. Thermo Fisher Scientific Inc.
- 13.3.6. Randox Laboratories Ltd.
- 13.3.7. Ortho Clinical Diagnostics
- 13.3.8. Quest Diagnostics Incorporated
- 13.3.9. Bio-Rad Laboratories, Inc.
- 13.3.10. Horiba, Ltd.
- 13.3.11. Sysmex Corporation
- 13.3.12. Tosoh Corporation
- 13.3.13. DiaSorin S.p.A.
- 13.3.14. Merck KGaA
- 13.3.15. Becton, Dickinson and Company (BD)
- 13.3.16. Abaxis, Inc. (Zoetis)
- 13.3.17. Biosystems S.A.
- 13.3.18. Genrui Biotech Inc.
- 13.3.19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 13.3.20. Helena Laboratories Corporation
- 14. Appendix
- 14.1. Research Methodology
- 14.2. Research Assumptions
- 14.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
